Communications
From CRDMO to BioInnovation Venture Accelerator: A Conversation with XL Lin, CEO of Esco Aster
Esco Aster has grown beyond a CRDMO, adding on a vertically integrated bioinnovation venture accelerator, offering “idea-to-exit” support that spans consultancy, CMC development, manufacturing, testing, clinical development, business development, and strategic investment. CEO XL Lin shares how this evolution came about, what sets Esco Aster’s Metamorphosis program apart, and what advice he has for Singapore’s next generation of bioentrepreneurs.
